Suchergebnisse - "Aspirin/therapeutic use"
-
1
Autoren: et al.
Quelle: Shoamanesh, A, Field, T S, Coutts, S B, Sharma, M, Gladstone, D, Hart, R G, Boriani, G, Wright, D J, Sticherling, C, Birnie, D H, Gold, M R, Erath, J W, Kutyifa, V, Mian, R, Benz, A P, Granger, C B, McIntyre, W F, Connolly, S J, Nielsen, J C, Alings, M, Rivard, L, Lopes, R D & Healey, J S 2025, 'Apixaban versus aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischaemic attack : subgroup analysis of the ARTESiA randomised controlled trial', The Lancet Neurology, vol. 24, no. 2, pp. 140-151. https://doi.org/10.1016/S1474-4422(24)00475-7
Schlagwörter: Aged, 80 and over, Male, Aspirin, Atrial Fibrillation/drug therapy, Pyridones, Middle Aged, Stroke, Pyrazoles/therapeutic use, Secondary Prevention/methods, Double-Blind Method, Ischemic Attack, Transient, Aspirin/therapeutic use, Atrial Fibrillation, Secondary Prevention, Humans, Pyrazoles, Female, Pyridones/therapeutic use, Factor Xa Inhibitors/therapeutic use, Ischemic Attack, Transient/prevention & control, Stroke/prevention & control, Platelet Aggregation Inhibitors, Aged, Factor Xa Inhibitors
-
2
Autoren: et al.
Quelle: Harrison, C N, Barbui, T, Bose, P, Kiladjian, J-J, Mascarenhas, J, McMullin, M F, Mesa, R & Vannucchi, A M 2025, 'Polycythaemia vera', Nature reviews. Disease primers, vol. 11, 26. https://doi.org/10.1038/s41572-025-00608-3
Schlagwörter: Janus Kinase 2/genetics, Hydroxyurea/therapeutic use, Mutation/genetics, Aspirin, Janus Kinase 2, Pyrazoles/therapeutic use, Pyrimidines, Polycythemia Vera/genetics, Risk Factors, Aspirin/therapeutic use, Mutation, Nitriles, Humans, Hydroxyurea, Pyrazoles, name=SDG 3 - Good Health and Well-being, Polycythemia Vera
Dateibeschreibung: application/pdf
-
3
Autoren: et al.
Quelle: Journal of Lipid Research, 66 (7), 100837 (2025-07)
Schlagwörter: arachidonic acid, cell signaling, colon, lipolysis and fatty acid metabolism, lipoxygenase, omega-3 fatty acids, phospholipids/metabolism, prostaglandins, Alox15 protein, mouse, Alox5 protein, mouse, Arachidonate Lipoxygenases, Aspirin, Cyclooxygenase Inhibitors, Dextran Sulfate, Fatty Acids, Omega-3, Fatty Acids, Omega-6, Oxylipins, Prostaglandin-Endoperoxide Synthases, Prostaglandins, Arachidonate 12-Lipoxygenase, Arachidonate 15-Lipoxygenase, Arachidonate 5-Lipoxygenase, Animals, Female, Mice, Arachidonate Lipoxygenases/metabolism, Aspirin/therapeutic use, Cell Line, Tumor, Colitis/chemically induced, Colitis/complications, Colon/metabolism, Colon/parasitology, Cyclooxygenase Inhibitors/therapeutic use, Host-Parasite Interactions, Lipidomics, Nematospiroides dubius/physiology, Prostaglandin-Endoperoxide Synthases/metabolism, Fatty Acids, Omega-3/administration & dosage, Fatty Acids, Omega-3/metabolism, Fatty Acids, Omega-6/administration & dosage, Fatty Acids, Omega-6/metabolism, Oxylipins/metabolism, Prostaglandins/metabolism, Strongylida Infections/complications, Colitis-Associated Neoplasms/metabolism, Colitis-Associated Neoplasms/parasitology, Colitis-Associated Neoplasms/prevention & control, Human health sciences, Immunology & infectious disease, Sciences de la santé humaine, Immunologie & maladie infectieuse
Relation: https://api.elsevier.com/content/article/PII:S0022227525000975?httpAccept=text/xml; urn:issn:0022-2275; urn:issn:1539-7262
Zugangs-URL: https://orbi.uliege.be/handle/2268/334993
-
4
Autoren: et al.
Quelle: Thaarup, M, Jacobsen, S, Nielsen, P B, Nicolajsen, C W, Eldrup, N, Petersen, C N, Behrendt, C-A, Dahl, M, Højen, A A & Søgaard, M 2024, 'Adherence and Persistence to Antiplatelet Therapy in Lower Extremity Peripheral Arterial Disease: A Danish Population Based Cohort Study', European Journal of Vascular and Endovascular Surgery, vol. 67, no. 6, pp. 948-957. https://doi.org/10.1016/j.ejvs.2024.02.002
Thaarup, M, Jacobsen, S, Nielsen, P B, Nicolajsen, C W, Eldrup, N, Petersen, C N, Behrendt, C A, Dahl, M, Højen, A A & Søgaard, M 2024, ' Adherence and Persistence to Antiplatelet Therapy in Lower Extremity Peripheral Arterial Disease : A Danish Population Based Cohort Study ', European Journal of Vascular and Endovascular Surgery, vol. 67, no. 6, pp. 948-957 . https://doi.org/10.1016/j.ejvs.2024.02.002
Thaarup, M, Jacobsen, S, Nielsen, P B, Nicolajsen, C W, Eldrup, N, Petersen, C N, Behrendt, C-A, Dahl, M, Højen, A A & Søgaard, M 2024, 'Adherence and Persistence to Antiplatelet Therapy in Lower Extremity Peripheral Arterial Disease : A Danish Population Based Cohort Study', European Journal of Vascular and Endovascular Surgery, vol. 67, no. 6, pp. 948-957. https://doi.org/10.1016/j.ejvs.2024.02.002Schlagwörter: Male, Adult, Intermittent Claudication/drug therapy, Time Factors, Platelet Aggregation Inhibitors/therapeutic use, Lower Extremity/blood supply, Denmark, Clopidogrel/therapeutic use, Persistence, Peripheral Arterial Disease, Ischemia, 80 and over, Humans, Peripheral Arterial Disease/drug therapy, Aged, Aged, 80 and over, Assessment of Medication Adherence, Peripheral artery disease, Aspirin, Antiplatelet therapy, Secondary prevention, Middle Aged, Intermittent Claudication, Denmark/epidemiology, Clopidogrel, 3. Good health, Treatment Outcome, Lower Extremity, Adherence, Aspirin/therapeutic use, Medication Adherence/statistics & numerical data, Female, Platelet Aggregation Inhibitors, Ischemia/drug therapy
Dateibeschreibung: application/pdf
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38341174
http://www.scopus.com/inward/record.url?scp=85188679113&partnerID=8YFLogxK
https://vbn.aau.dk/ws/files/720772797/Thaarup_et_al._2024_._Adherence_and_Persistence_to_Antiplatelet_Therapy_in_Lower_Extremity_Peripheral_Arterial_Disease_-_A_Danish_Population_Based_Cohort_Study.pdf
https://doi.org/10.1016/j.ejvs.2024.02.002
https://vbn.aau.dk/da/publications/6ac6342d-6a5f-4232-9e6e-306428aaaf80
https://curis.ku.dk/ws/files/458105265/1-s2.0-S1078588424001618-main.pdf
https://portal.findresearcher.sdu.dk/da/publications/bbc6b89d-3d70-4f0a-8a31-318dd9bc5167
https://doi.org/10.1016/j.ejvs.2024.02.002
https://pure.au.dk/portal/en/publications/38ce934c-9bec-40c5-aa29-82dcb5120951
http://www.scopus.com/inward/record.url?scp=85188679113&partnerID=8YFLogxK
https://doi.org/10.1016/j.ejvs.2024.02.002 -
5
Autoren: et al.
Quelle: HNO
Schlagwörter: Biologika, Desaktivierung, Aged, 80 and over [MeSH], Sinusitis/diagnosis [MeSH], Aged [MeSH], Rhinitis/therapy [MeSH], Asthma bronchiale, Sinusitis/therapy [MeSH], Allergic rhinitis, Germany/epidemiology [MeSH], Nasal Polyps/diagnosis [MeSH], Desensitization, Immunologic/methods [MeSH], Originalien, Male [MeSH], Chronic Disease [MeSH], Antikörper, Combined Modality Therapy [MeSH], Child [MeSH], Biologicals, Rhinitis/diagnosis [MeSH], Antibodies, Adolescent [MeSH], Female [MeSH], Adult [MeSH], Humans [MeSH], Treatment Outcome [MeSH], Nasal Polyps/therapy [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Desensitization, Asthma, Adrenal Cortex Hormones/therapeutic use [MeSH], Rhinosinusitis [MeSH], Young Adult [MeSH], Allergische Rhinitis, Aspirin/therapeutic use [MeSH], Rhinitis/drug therapy [MeSH], Nasal Polyps/complications [MeSH], Child, Preschool [MeSH], Sinusitis/drug therapy [MeSH]
Dateibeschreibung: application/pdf
-
6
Autoren: et al.
Quelle: World J Urol
Schlagwörter: Male, Adult, Aspirin, Research, Blood Loss, Surgical, Female [MeSH], Kidney transplantation, Aged [MeSH], Adult [MeSH], Humans [MeSH], Thrombosis, Tissue Donors [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Platelet Aggregation Inhibitors/therapeutic use [MeSH], Bleeding, Blood Loss, Surgical [MeSH], Postoperative Hemorrhage/epidemiology [MeSH], Aspirin/adverse effects [MeSH], Male [MeSH], Anticoagulants, Kidney Transplantation [MeSH], Acetyl salycilic acid, Platelet Aggregation Inhibitors/adverse effects [MeSH], Aspirin/therapeutic use [MeSH], Middle Aged, Postoperative Hemorrhage, Kidney Transplantation, Tissue Donors, Humans, Female, Platelet Aggregation Inhibitors, Retrospective Studies, Aged
-
7
Autoren: et al.
Schlagwörter: PATIENT SATISFACTION, PHYSICIAN-PATIENT RELATIONS, MEDICATION ADHERENCE – psychology, MULTIMORBIDITY, PATIENT EDUCATION AS TOPIC, PATIENT COMPLIANCE – psychology, POLYPHARMACY, ACUTE CORONARY SYNDROME – drug therapy, psychology, SURVEYS AND QUESTIONNAIRES, ASPIRIN – therapeutic use
Dateibeschreibung: application/pdf
Zugangs-URL: https://urn.nsk.hr/urn:nbn:hr:105:744041
-
8
Autoren: et al.
Weitere Verfasser: et al.
Quelle: Annals of neurology, vol. 95, no. 5, pp. 886-897
Kaufmann, Josefin E; Gensicke, Henrik; Schaedelin, Sabine; Luft, Andreas R; Goeggel-Simonetti, Barbara; Fischer, Urs; Michel, Patrik; Strambo, Davide; Kägi, Georg; Vehoff, Jochen; Nedeltchev, Krassen; Kahles, Timo; Kellert, Lars; Rosenbaum, Sverre; von Rennenberg, Regina; Riegler, Christoph; Seiffge, David; Sarikaya, Hakan; Zietz, Annaelle; Wischmann, Johannes; ... (2024). Toward Individual Treatment in Cervical Artery Dissection: Subgroup Analysis of the TREAT-CAD Randomized Trial. Annals of neurology, 95(5), pp. 886-897. Wiley-Blackwell 10.1002/ana.26886 <http://dx.doi.org/10.1002/ana.26886>Schlagwörter: Male, Vertebral Artery Dissection, Adult, Aspirin, Anticoagulants, 610 Medicine & health, Middle Aged, 16. Peace & justice, Humans, Female, Vertebral Artery Dissection/drug therapy, Vertebral Artery Dissection/diagnostic imaging, Vertebral Artery Dissection/complications, Aspirin/therapeutic use, Anticoagulants/therapeutic use, Fibrinolytic Agents/therapeutic use, Aged, Treatment Outcome, 3. Good health, Fibrinolytic Agents
Dateibeschreibung: application/pdf
-
9
Autoren: et al.
Quelle: Am J Cardiovasc Drugs
Schlagwörter: Stroke, ddc:610, Peripheral Arterial Disease, Aspirin, Rivaroxaban, Cost-Benefit Analysis, Myocardial Infarction, Humans, Drug Therapy, Combination, Original Research Article, Peripheral Arterial Disease/drug therapy [MeSH], Cost-Benefit Analysis [MeSH], Factor Xa Inhibitors [MeSH], Myocardial Infarction/prevention, Humans [MeSH], Aspirin/therapeutic use [MeSH], Rivaroxaban/therapeutic use [MeSH], Drug Therapy, Combination [MeSH], Stroke/prevention, Rivaroxaban/economics [MeSH], Aspirin/economics [MeSH], Factor Xa Inhibitors
Dateibeschreibung: application/pdf
-
10
Autoren: et al.
Weitere Verfasser: et al.
Quelle: J Thromb Haemost
Kanagaratnam, P, Francis, D P, Chamie, D, Coyle, C, Marynina, A, Katritsis, G, Paiva, P, Szigeti, M, Cole, G, de Andrade Nunes, D, Howard, J, Esper, R, Khan, M, More, R, Barreto, G, Meneguz-Moreno, R, Arnold, A, Nowbar, A, Kaura, A, Mariveles, M, March, K, Shah, J, Nijjer, S, Lip, G Y H, Mills, N, Camm, A J, Cooke, G S, Corbett, S J, Llewelyn, M J, Ghanima, W, Toshner, M, Peters, N, Petraco, R, Al-Lamee, R, Boshoff, A S M, Durkina, M, Malik, I, Ruparelia, N, Cornelius, V & Shun-Shin, M 2023, 'A randomized controlled trial to investigate the use of acute coronary syndrome therapy in patients hospitalized with COVID-19 : the COVID-19 Acute Coronary Syndrome trial', Journal of Thrombosis and Haemostasis, vol. 21, no. 8, pp. 2213-2222. https://doi.org/10.1016/j.jtha.2023.04.045
Kanagaratnam, P, Francis, D P, Chamie, D, Coyle, C, Marynina, A, Katritsis, G, Paiva, P, Szigeti, M, Cole, G, de Andrade Nunes, D, Howard, J, Esper, R, Khan, M, More, R, Barreto, G, Meneguz-Moreno, R, Arnold, A, Nowbar, A, Kaura, A, Mariveles, M, March, K, Shah, J, Nijjer, S, Lip, G Y H, Mills, N, Camm, A J, Cooke, G S, Corbett, S J, Llewelyn, M J, Ghanima, W, Toshner, M, Peters, N, Petraco, R, Al-Lamee, R, Boshoff, A S M, Durkina, M, Malik, I, Ruparelia, N, Cornelius, V & Shun-Shin, M 2023, ' A randomized controlled trial to investigate the use of acute coronary syndrome therapy in patients hospitalized with COVID-19 : the COVID-19 Acute Coronary Syndrome trial ', Journal of Thrombosis and Haemostasis, vol. 21, no. 8, pp. 2213-2222 . https://doi.org/10.1016/j.jtha.2023.04.045Schlagwörter: Aspirin, SARS-CoV-2, COVID-19, Bayes Theorem, Hemorrhage, anticoagulant agent, antiplatelet agent, Acute Coronary Syndrome/diagnosis, ischemic heart disease, 3. Good health, COVID-19 infection, Treatment Outcome, Hemorrhage/chemically induced, Aspirin/therapeutic use, randomized controlled trial, Humans, Original Article, Acute Coronary Syndrome, thrombosis
Dateibeschreibung: application/pdf
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/37230416
https://vbn.aau.dk/ws/files/546388252/Kanagaratnam_et_al._2023_._A_randomized_controlled_trial_to_investigate_the_use_of_acute_coronary_syndrome_therapy_in_patients_hospitalized_with_COVID-19_-_the_COVID-19_Acute_Coronary_Syndrome_trial.pdf
https://doi.org/10.1016/j.jtha.2023.04.045
https://vbn.aau.dk/da/publications/3334f54b-2a8c-46c6-a07b-13794e390e98
https://www.pure.ed.ac.uk/ws/files/414130025/PIIS1538783623004282.pdf
https://hdl.handle.net/20.500.11820/8fa034f9-0a34-4ecf-962c-30373a880e25 -
11
Autoren: et al.
Quelle: Schjødt, I, Mols, R E, Eiskjær, H, Bakos, I, Horváth-Puhó, E, Gustafsson, F, Kristensen, S L, Larsson, J E & Løgstrup, B B 2023, 'Long-Term Medical Treatment and Adherence in Patients With Left Ventricular Assist Devices : A Danish Nationwide Cohort Study', ASAIO Journal, vol. 69, no. 12, pp. E482-E490. https://doi.org/10.1097/MAT.0000000000002057
Schlagwörter: left ventricular assist advice, Heart Failure, multimorbidity, Aspirin, Denmark, medication use, Warfarin/therapeutic use, heart failure, socioeconomic factors, Heart Failure/drug therapy, Heart-Assist Devices/adverse effects, 3. Good health, Cohort Studies, Treatment Outcome, Aspirin/therapeutic use, medication adherence, Humans, Warfarin, Heart-Assist Devices, Retrospective Studies
-
12
Autoren: et al.
Quelle: Global Heart, 20 (1), 83 (2025)
Schlagwörter: acute coronary syndrome treatment, cardiovascular polypill, expert consensus, real-world practice, secondary prevention, Ramipril, Atorvastatin, Aspirin, Drug Combinations, Angiotensin-Converting Enzyme Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Humans, Delphi Technique, Consensus, Angiotensin-Converting Enzyme Inhibitors/administration & dosage, Drug Therapy, Combination, Ramipril/administration & dosage, Atorvastatin/administration & dosage, Secondary Prevention/methods, Aspirin/administration & dosage, Aspirin/therapeutic use, Cardiovascular Diseases/prevention & control, Cardiovascular Diseases, Epidemiology, Community and Home Care, Cardiology and Cardiovascular Medicine, Human health sciences, Cardiovascular & respiratory systems, Sciences de la santé humaine, Systèmes cardiovasculaire & respiratoire
Relation: https://account.globalheartjournal.com/index.php/up-j-gh/article/download/1466/2099; urn:issn:2211-8160; urn:issn:2211-8179
Zugangs-URL: https://orbi.uliege.be/handle/2268/337991
-
13
Autoren: et al.
Weitere Verfasser: et al.
Quelle: Komen, J J, Hunt, N B, Pottegård, A, Hjemdahl, P, Wettermark, B, Olesen, M, Bennie, M, Mueller, T, Carragher, R, Karlstad, Ø, Kjerpeseth, L J, Klungel, O H & Forslund, T 2023, 'Heterogeneity after harmonisation: a retrospective cohort study of bleeding and stroke risk after the introduction of direct oral anticoagulants in four Western European countries', Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.5650
Schlagwörter: Oral, Epidemiology, Administration, Oral, Hemorrhage, Stroke/epidemiology, Kardiologi och kardiovaskulära sjukdomar, Hemorrhage/chemically induced, Atrial Fibrillation, Humans, Cardiac and Cardiovascular Systems, Pharmacology (medical), multi-database, Retrospective Studies, Kardiologi, Aspirin, Anticoagulants, Public Health, Global Health, Social Medicine and Epidemiology, Folkhälsovetenskap, global hälsa och socialmedicin, anti-coagulants, Public Health, Global Health and Social Medicine, bleeding, utilisation, stroke, 3. Good health, Stroke, Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi, Administration, Aspirin/therapeutic use, Therapeutics. Pharmacology, heterogeneity, Atrial Fibrillation/complications, Cardiology and Cardiovascular Disease
Dateibeschreibung: application/pdf; text
-
14
Autoren: et al.
Quelle: BMC Med Res Methodol
BMC Medical Research Methodology, Vol 24, Iss 1, Pp 1-9 (2024)Schlagwörter: Male, Medicine (General), Disability-free longevity, Risk Assessment, 01 natural sciences, Aged [MeSH], United States [MeSH], Outcome Assessment, Health Care/statistics, Randomized Controlled Trials as Topic/methods [MeSH], Aspirin, Risk Assessment/statistics, Data science methodologies, Proportional Hazards Models [MeSH], Decision Trees [MeSH], Male [MeSH], Models, Statistical [MeSH], Randomized Controlled Trials as Topic/statistics, Machine Learning [MeSH], Outcome risk modelling, Risk Assessment/methods [MeSH], Female [MeSH], Humans [MeSH], Random forest, Treatment Outcome [MeSH], Heterogeneity of treatment effect, Outcome Assessment, Health Care/methods [MeSH], Research, Clinical trial, Aspirin/therapeutic use [MeSH], Decision tree, Machine Learning, 03 medical and health sciences, R5-920, 0302 clinical medicine, Outcome Assessment, Health Care, Humans, 0101 mathematics, Aged, Proportional Hazards Models, Randomized Controlled Trials as Topic, Models, Statistical, Decision Trees, 16. Peace & justice, United States, 3. Good health, Treatment Outcome, Female
-
15
Autoren: et al.
Quelle: Kristensen, A M D, Pareek, M, Kragholm, K H, Torp-Pedersen, C, McEvoy, J W & Prescott, E B 2023, 'Temporal trends in low-dose aspirin therapy for primary prevention of cardiovascular disease in European adults with and without diabetes', European Journal of Preventive Cardiology, vol. 30, no. 12, zwad092, pp. 1172-1181. https://doi.org/10.1093/eurjpc/zwad092
Schlagwörter: Adult, Male, Temporal trends, Diabetes Mellitus/drug therapy, Europe/epidemiology, Diabetes Mellitus, Humans, Aged, Aged, 80 and over, Primary prevention, Aspirin, Cardiovascular Diseases/epidemiology, Hypertension/drug therapy, Diabetes, Middle Aged, Cardiovascular disease, Primary Prevention/methods, 3. Good health, Europe, Primary Prevention, Cardiovascular Diseases, Heart Disease Risk Factors, Aspirin/therapeutic use, Practice Guidelines as Topic, Diabetes Mellitus/epidemiology, Primary Prevention/trends, Female, Cardiovascular Diseases/prevention & control
-
16
Autoren: et al.
Quelle: The American journal of cardiology, vol. 190, pp. 61-66
Schlagwörter: Primary Prevention, 03 medical and health sciences, 0302 clinical medicine, Aspirin, Cardiovascular Diseases, Humans, Cardiovascular Diseases/epidemiology, Cardiovascular Diseases/prevention & control, Cardiovascular Diseases/drug therapy, Aspirin/therapeutic use, Anticoagulants/therapeutic use, Anticoagulants, 16. Peace & justice, 3. Good health
Dateibeschreibung: application/pdf
-
17
Autoren: et al.
Weitere Verfasser: et al.
Quelle: American Heart Journal, 254, pp. 141-148
Schlagwörter: Radboudumc 18: Healthcare improvement science RIHS: Radboud Institute for Health Sciences, Genotype, Platelet Aggregation Inhibitors/therapeutic use, Myocardial Infarction/drug therapy, Myocardial Infarction, Radboud University Medical Center, Clopidogrel/therapeutic use, Pharmacology-Toxicology - Radboud University Medical Center, Peripheral Arterial Disease, 03 medical and health sciences, Radboudumc 16: Vascular damage RIHS: Radboud Institute for Health Sciences, 0302 clinical medicine, Journal Article, Humans, Internal Medicine - Radboud University Medical Center, Peripheral Arterial Disease/drug therapy, Aspirin, Thrombosis/drug therapy, Thrombosis, Clopidogrel, 3. Good health, Multicenter Study, Cytochrome P-450 CYP2C19, Treatment Outcome, Randomized Controlled Trial, Aspirin/therapeutic use, Radboudumc 5: Inflammatory diseases RIHS: Radboud Institute for Health Sciences, Radboudumc 0: Other Research RIHS: Radboud Institute for Health Sciences, Cytochrome P-450 CYP2C19/genetics, Platelet Aggregation Inhibitors, Surgery - Radboud University Medical Center
Dateibeschreibung: application/pdf
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/35988587
https://hdl.handle.net/11370/6a261d34-34ba-4a4b-bdde-6d7e483bc2b5
https://research.rug.nl/en/publications/6a261d34-34ba-4a4b-bdde-6d7e483bc2b5
https://doi.org/10.1016/j.ahj.2022.08.001
https://research-portal.uu.nl/en/publications/403b5da4-3057-4906-bf85-fabd1c9e8097
https://doi.org/10.1016/j.ahj.2022.08.001
https://dspace.library.uu.nl/handle/1874/448110
https://hdl.handle.net/2066/283874
https://repository.ubn.ru.nl//bitstream/handle/2066/283874/283874.pdf
https://dspace.library.uu.nl/handle/1874/425766 -
18
Autoren: Schranz, Dietmar
Quelle: Pediatr Cardiol
Schlagwörter: Dose-Response Relationship, Drug [MeSH], Infant, Newborn [MeSH], Humans [MeSH], Aspirin, Heart Defects, Congenital/surgery [MeSH], Heart Defects, Congenital/drug therapy [MeSH], Platelet Aggregation Inhibitors/therapeutic use [MeSH], Aspirin/administration, Platelet Aggregation Inhibitors/administration, Infant [MeSH], Neonates, Congenital heart disease, Aspirin/pharmacology [MeSH], Aspirin/therapeutic use [MeSH], Dosage, Child [MeSH], Correspondence, Platelet Aggregation Inhibitors/pharmacology [MeSH]
-
19
Autoren: et al.
Weitere Verfasser: et al.
Quelle: EuroIntervention. 18:471-481
Schlagwörter: Ticlopidine, Coronary Artery Disease* / drug therapy, Hemorrhage, Coronary Artery Disease, Aspirin / therapeutic use, Percutaneous Coronary Intervention* / methods, 03 medical and health sciences, Percutaneous Coronary Intervention, 0302 clinical medicine, Drug Therapy, Hemorrhage / etiology, Humans, Acute Coronary Syndrome, Drug-Eluting Stents, Aspirin, Ticlopidine / therapeutic use, Platelet Aggregation Inhibitors / therapeutic use, Clopidogrel / therapeutic use, Clopidogrel, 3. Good health, Treatment Outcome, Combination, Acute Coronary Syndrome* / surgery, Drug Therapy, Combination, Acute Coronary Syndrome* / drug therapy, Coronary Artery Disease* / surgery, Platelet Aggregation Inhibitors
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/35470799
-
20
Autoren: et al.
Quelle: Cancer Prev Res (Phila)
Mathers, J C, Elliott, F, Macrae, F, Mecklin, J-P, Möslein, G, McRonald, F E, Bertario, L, Evans, D G, Gerdes, A-M, Ho, J W C, Lindblom, A, Morrison, P J, Rashbass, J, Ramesar, R S, Seppälä, T T, Thomas, H J W, Sheth, H J, Pylvänäinen, K, Reed, L, Borthwick, G M, Bishop, D T & Burn, J 2022, 'Cancer Prevention with Resistant Starch in Lynch Syndrome Patients in the CAPP2-Randomized Placebo Controlled Trial: Planned 10-Year Follow-up', Cancer prevention research (Philadelphia, Pa.), vol. 15, no. 9, pp. 623–634. https://doi.org/10.1158/1940-6207.CAPR-22-0044
the CAPP2 Investigators 2022, ' Cancer Prevention with Resistant Starch in Lynch Syndrome Patients in the CAPP2-Randomized Placebo Controlled Trial : Planned 10-Year Follow-up ', Cancer Prevention Research, vol. 15, no. 9, pp. 623-634 . https://doi.org/10.1158/1940-6207.CAPR-22-0044
Mathers, J C, Elliott, F, Macrae, F, Mecklin, J-P, Möslein, G, McRonald, F E, Bertario, L, Evans, D G, Gerdes, A-M, Ho, J W C, Lindblom, A, Morrison, P J, Rashbass, J, Ramesar, R S, Seppälä, T T, Thomas, H J W, Sheth, H J, Pylvänäinen, K, Reed, L, Borthwick, G M, Bishop, D T & Burn, J 2022, 'Cancer Prevention with Resistant Starch in Lynch Syndrome Patients in the CAPP2-Randomized Placebo Controlled Trial: Planned 10-Year Follow-up', Cancer Prevention Research, vol. 15, no. 9, pp. 623-634. https://doi.org/10.1158/1940-6207.CAPR-22-0044Schlagwörter: tärkkelys, 03 medical and health sciences, 0302 clinical medicine, asetyylisalisyylihappo, Humans, name=SDG 3 - Good Health and Well-being, Lynchin oireyhtymä, Research Articles, paksusuolisyöpä, Aspirin, Incidence, Resistant Starch, Colorectal Neoplasms/drug therapy, 16. Peace & justice, Colorectal Neoplasms, Hereditary Nonpolyposis, Hereditary Nonpolyposis/complications, 3. Good health, Aspirin/therapeutic use, syöpätaudit, ennaltaehkäisy, seurantatutkimus, Colorectal Neoplasms, Hereditary Nonpolyposis/complications, ilmaantuvuus, Colorectal Neoplasms, Follow-Up Studies
Dateibeschreibung: application/pdf; fulltext; text
Full Text Finder 
Nájsť tento článok vo Web of Science 
Full Text